Rating Change
Keybanc reiterated its Overweight rating on Castle Biosciences, Inc. (NASDAQ:CSTL) on November 06, 2026.
reiterateNASDAQ:CSTL
Keybanc Reiterates Overweight Rating on Castle Biosciences, Inc. (CSTL)
Keybanc reiterated its Overweight rating on Castle Biosciences, Inc. (NASDAQ:CSTL) on November 06, 2026.
At publication ·
What changed
Castle Biosciences, Inc. (NASDAQ:CSTL) · reiterate
- Firm
- Keybanc
- Rating
- Overweight to Overweight
- Price at event
- $32.28
- Market capitalization
- $1.1B
At a glance
Key takeaways
- Keybanc reiterated an Overweight rating on Castle Biosciences (CSTL) on November 6, 2026, with the stock trading at $32.28 and a market cap of $1.1 billion.
Market Context
Castle Biosciences, Inc. operates in the Healthcare sector. The stock currently trades at $32.28 with a market capitalization of $1.1B.
Analyst coverage from Keybanc provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Castle Biosciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Castle Biosciences, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 06, 2026 | Keybanc | Overweight | N/A |
| Aug 03, 2026 | BTIG | Buy | N/A |
| Jun 25, 2026 | Roth Capital | Buy | N/A |
| May 13, 2026 | BTIG | Buy | N/A |
| May 07, 2026 | Baird | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View CSTL Stock Page
Frequently Asked Questions
What does the Overweight rating mean for CSTL?
A rating of Overweight from Keybanc reflects the analyst's outlook on Castle Biosciences, Inc. (NASDAQ:CSTL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CSTL forecast page.